329 related articles for article (PubMed ID: 30391550)
21. Hematopoietic stem cell transplantation in an infant with dedicator of cytokinesis 8 (DOCK8) deficiency associated with systemic lupus erythematosus: A case report.
Seo E; Lee BH; Lee JH; Park YS; Im HJ; Lee J
Medicine (Baltimore); 2021 Apr; 100(13):e20866. PubMed ID: 33787566
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
23. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
Aydin SE; Kilic SS; Aytekin C; Kumar A; Porras O; Kainulainen L; Kostyuchenko L; Genel F; Kütükcüler N; Karaca N; Gonzalez-Granado L; Abbott J; Al-Zahrani D; Rezaei N; Baz Z; Thiel J; Ehl S; Marodi L; Orange JS; Sawalle-Belohradsky J; Keles S; Holland SM; Sanal Ö; Ayvaz DC; Tezcan I; Al-Mousa H; Alsum Z; Hawwari A; Metin A; Matthes-Martin S; Hönig M; Schulz A; Picard C; Barlogis V; Gennery A; Ifversen M; van Montfrans J; Kuijpers T; Bredius R; Dückers G; Al-Herz W; Pai SY; Geha R; Notheis G; Schwarze CP; Tavil B; Azik F; Bienemann K; Grimbacher B; Heinz V; Gaspar HB; Aydin R; Hagl B; Gathmann B; Belohradsky BH; Ochs HD; Chatila T; Renner ED; Su H; Freeman AF; Engelhardt K; Albert MH;
J Clin Immunol; 2015 Feb; 35(2):189-98. PubMed ID: 25627830
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
25. Treatment options for DOCK8 deficiency-related severe dermatitis.
Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
[TBL] [Abstract][Full Text] [Related]
26. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
Strocchio L; Zecca M; Comoli P; Mina T; Giorgiani G; Giraldi E; Vinti L; Merli P; Regazzi M; Locatelli F
Br J Haematol; 2015 Jun; 169(5):726-36. PubMed ID: 25818248
[TBL] [Abstract][Full Text] [Related]
27. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
Jacobsohn DA; Duerst R; Tse W; Kletzel M
Lancet; 2004 Jul 10-16; 364(9429):156-62. PubMed ID: 15246728
[TBL] [Abstract][Full Text] [Related]
28. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience From a Tertiary Medical Center.
Rousso SZ; Shamriz O; Zilkha A; Braun J; Averbuch D; Or R; Weintraub M; Revel-Vilk S; Stepensky P
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e295-300. PubMed ID: 25985240
[TBL] [Abstract][Full Text] [Related]
30. Dedicator of cytokinesis 8-deficient CD4
Tangye SG; Pillay B; Randall KL; Avery DT; Phan TG; Gray P; Ziegler JB; Smart JM; Peake J; Arkwright PD; Hambleton S; Orange J; Goodnow CC; Uzel G; Casanova JL; Lugo Reyes SO; Freeman AF; Su HC; Ma CS
J Allergy Clin Immunol; 2017 Mar; 139(3):933-949. PubMed ID: 27554822
[TBL] [Abstract][Full Text] [Related]
31. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
33. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.
Mizesko MC; Banerjee PP; Monaco-Shawver L; Mace EM; Bernal WE; Sawalle-Belohradsky J; Belohradsky BH; Heinz V; Freeman AF; Sullivan KE; Holland SM; Torgerson TR; Al-Herz W; Chou J; Hanson IC; Albert MH; Geha RS; Renner ED; Orange JS
J Allergy Clin Immunol; 2013 Mar; 131(3):840-8. PubMed ID: 23380217
[TBL] [Abstract][Full Text] [Related]
34. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.
Al-Herz W; Ragupathy R; Massaad MJ; Al-Attiyah R; Nanda A; Engelhardt KR; Grimbacher B; Notarangelo L; Chatila T; Geha RS
Clin Immunol; 2012 Jun; 143(3):266-72. PubMed ID: 22534316
[TBL] [Abstract][Full Text] [Related]
35. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
[TBL] [Abstract][Full Text] [Related]
36. Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases.
Umeda K; Imai K; Yanagimachi M; Yabe H; Kobayashi M; Takahashi Y; Kajiwara M; Yoshida N; Cho Y; Inoue M; Hashii Y; Atsuta Y; Morio T;
Int J Hematol; 2020 Jun; 111(6):869-876. PubMed ID: 32052319
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Ahmed N; Leung KS; Rosenblatt H; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1298-304. PubMed ID: 18940685
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
[TBL] [Abstract][Full Text] [Related]
39. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.
Jing H; Zhang Q; Zhang Y; Hill BJ; Dove CG; Gelfand EW; Atkinson TP; Uzel G; Matthews HF; Mustillo PJ; Lewis DB; Kavadas FD; Hanson IC; Kumar AR; Geha RS; Douek DC; Holland SM; Freeman AF; Su HC
J Allergy Clin Immunol; 2014 Jun; 133(6):1667-75. PubMed ID: 24797421
[TBL] [Abstract][Full Text] [Related]
40. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
